Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Noelle Pouget"'
Autor:
Juliana Bruder Costa, Tania Dufeu-Duchesne, Vincent Leroy, Inga Bertucci, Magali Bouvier-Alias, Noelle Pouget, Ophelie Brevot-Lutton, Marc Bourliere, Fabien Zoulim, Joel Plumas, Caroline Aspord, ANRS HB06 PEGAN study group
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0158297 (2016)
Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune res
Externí odkaz:
https://doaj.org/article/af79ddd97184467bb9fcba0f5e0b0db9
Autor:
Caroline Aspord, Juliana Bruder Costa, Marie-Christine Jacob, Tania Dufeu-Duchesne, Inga Bertucci, Noelle Pouget, Ophelie Brevot-Lutton, Fabien Zoulim, Marc Bourliere, Joel Plumas, Vincent Leroy, ANRS HB06 PEGAN study group
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156200 (2016)
The ultimate goal of pegylated interferon-alfa-2a (Peg-IFN-α) therapy in chronic hepatitis B (CHB) infection is HBsAg seroconversion. Even though B cells are major mediators of a positive clinical outcome, their modulation during Peg-IFN-α therapy
Externí odkaz:
https://doaj.org/article/2c9f4f68ed5142e791cc06a6d45d60c5
Autor:
Ophelie Brevot-Lutton, Noelle Pouget, Tania Dufeu-Duchesne, Caroline Aspord, Magali Bouvier-Alias, Joel Plumas, Marc Bourlière, Juliana Bruder Costa, Vincent Leroy, Inga Bertucci, Fabien Zoulim
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, Vol 11, Iss 6, p e0158297 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, Vol 11, Iss 6, p e0158297 (2016)
International audience; Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8752d10abb37073884400d7f94f919
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01427005
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01427005